In early spring and February, it was a beautiful day. Dr. Chen Huimin, CEO/ founder of Huaxia Siyin (Shanghai) Biotechnology Co., Ltd. and his delegation visited Huzhou Central Hospital for field visit and exchange.

　　Huzhou Central Hospital was founded in 1931, covering an area of about 500 mu of land and water. The first phase covers an area of 250 mu. The second phase of the new hospital project (Huzhou Public Health Clinical Center) has started construction, with a total investment of 1.06 billion yuan and a planned land area of 70 mu. Formerly known as Zhejiang Provincial Hospital, Huzhou Central Hospital provides medical care for more than 4 million people in Huzhou, Xuancheng of Anhui Province and Wujiang of Jiangsu Province. The hospital has a variety of imported and domestic medical equipment and advanced laboratories.

　Huzhou Central Hospital and Huaxia Siyin had an in-depth exchange on future strategic cooperation.

Participants of Huzhou Central Hospital:

Secretary of the Party Committee of Huzhou Central Hospital Ma Jianming

Vice President of Huzhou Central Hospital Strict and strong

Deputy Director of Department of Pharmacy, Deputy Director of Office of Clinical Trial Institution Shen Minmin

Deputy Director of Scientific Research Department, Deputy Director of Results Transformation Office. Shen Guodi

Deputy Director of the Department of Orthopedics Li Jianyou

Deputy Director of the Department of Orthopedics Lu Qian

Head, Rehabilitation (Sports Medicine) Wu Fengfeng

Director of Infectious Diseases Tong Zhaowei

Huaxia Siyin participants are:

CEO/ Founder of Huaxia Siyin Chen Huimin doctor

Conversion Manager Dr. Chen Xifang

Product Manager Huang Guotao

Production Manager; Xu Linyu

　During the cooperation and exchange, Yan Qiang, Vice president of Huzhou Central Hospital, introduced in detail the hospital layout, general situation and the progress of the hospital's ongoing projects, as well as the efforts in building a more excellent, deeper, more dynamic, more quality, more responsibility, more delicate, more warm and more ambitious public hospital.

　　Dr. Chen Huimin, CEO/ founder of Huaxia Siyin, introduced the general situation of Huaxia Siyin and five ongoing projects:

1. Triple bionics to promote cartilage regeneration and repair based on 3D printing platform technology;

2. In situ injection and curing of bio-ink for minimally invasive tissue filling;

3. Construction and application of 3D printing double-layer skin organoids model;

4. Treatment of Crohn's complex anal fistula with human umbilical cord mesenchymal stem cell hydrogel;

5. Application development of drug sensitivity and drug screen based on tumor organoid technology.

Both parties reached preliminary cooperation intention on relevant cooperation matters. Secretary Ma looked forward to an early success and fruitful cooperation.

Dr. Chen Huimin said: Huzhou Central Hospital is a very modern hospital of the future. Huaxia Siyin hopes to promote the clinical transformation process of multiple projects in Huzhou Central Hospital through close and long-term cooperation with Huzhou Central Hospital, so that a large number of patients can benefit from better treatment brought by modern technology.